Profile change history

What changed for Thymopentin?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Thymopentin identity.

32Total events
32Record additions
0Version changes
9Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 32 connected records →

Showing the latest 32 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

ClinicalTrials.gov record NCT00002049

PeptideScanner retained ClinicalTrials.gov record NCT00002049 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00002050

PeptideScanner retained ClinicalTrials.gov record NCT00002050 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00002051

PeptideScanner retained ClinicalTrials.gov record NCT00002051 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00002066

PeptideScanner retained ClinicalTrials.gov record NCT00002066 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00002109

PeptideScanner retained ClinicalTrials.gov record NCT00002109 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00002289

PeptideScanner retained ClinicalTrials.gov record NCT00002289 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00002332

PeptideScanner retained ClinicalTrials.gov record NCT00002332 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials
Record added

Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations.

PubMed lists PMID 1329673 in Archives of disease in childhood as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1992-09 (month precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 1, 2019
Evidence lane
Literature metadata
Record added

[Evaluation of the use of thymopentin in patients with progressive systemic sclerosis].

PubMed lists PMID 1828204 in La Clinica terapeutica as Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1991-03-31 (day precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Investigations on cell-mediated immunity in patients with breast and ovarian carcinomas receiving a combination of chemotherapy and immunotherapy with thymopentin.

PubMed lists PMID 2232966 in Methods and findings in experimental and clinical pharmacology as Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, with publication-date metadata of 1990-06 (month precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

[Peridural analgesia with dexamethasone and thymopentin: influence of the hypothalamo-hypophyseal axis].

PubMed lists PMID 2290529 in Minerva anestesiologica as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1990-10 (month precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Thymopentin (TP-5) in the treatment of rheumatoid arthritis.

PubMed lists PMID 2650797 in British journal of rheumatology as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1989-04 (month precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
August 28, 2019
Evidence lane
Literature metadata
Record added

Immunomodulation with thymopentin: in vitro studies.

PubMed lists PMID 2657246 in Medical oncology and tumor pharmacotherapy as Journal Article, Review, with publication-date metadata of 1989 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 29, 2019
Evidence lane
Literature metadata
Record added

Thymopentin in dermatology.

PubMed lists PMID 2663371 in Current problems in dermatology as Journal Article, Review, with publication-date metadata of 1989 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 29, 2019
Evidence lane
Literature metadata
Record added

Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.

PubMed lists PMID 2863860 in Survey of immunologic research as Clinical Trial, Journal Article, with publication-date metadata of 1985 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 20, 2026
Evidence lane
Literature metadata
Record added

Thymopoietin to thymopentin: experimental studies.

PubMed lists PMID 2994196 in Survey of immunologic research as Journal Article, Review, with publication-date metadata of 1985 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 1, 2019
Evidence lane
Literature metadata
Record added

Tetrahydro-β-carboline-3-carboxyl-thymopentin: a nano-conjugate for releasing pharmacophores to treat tumor and complications.

PubMed lists PMID 32263105 in Journal of materials chemistry. B as Journal Article, with publication-date metadata of 2015-12-24 (day precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
April 8, 2020
Evidence lane
Literature metadata
Record added

Experience with thymopentin in the treatment of periarthritis humeroscapularis, tendinitis, and gonarthrosis by local infiltration.

PubMed lists PMID 3284530 in Arzneimittel-Forschung as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1988-01 (month precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Preformulation studies of thymopentin: analytical method development, physicochemical properties, kinetic degradation investigations and formulation perspective.

PubMed lists PMID 35234086 in Drug development and industrial pharmacy as Journal Article, with publication-date metadata of 2022-03-15 (day precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 22, 2022
Evidence lane
Literature metadata
Record added

A prospective study of thymopentin in severely burned patients.

PubMed lists PMID 3554564 in Surgery, gynecology & obstetrics as Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1987-05 (month precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Thymopentin treatment of selective IgA deficiency.

PubMed lists PMID 3898285 in Survey of immunologic research as Clinical Trial, Controlled Clinical Trial, Journal Article, with publication-date metadata of 1985 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 1, 2019
Evidence lane
Literature metadata
Record added

Thymopentin treatment in patients with chemotherapy-resistant lepromatous leprosy.

PubMed lists PMID 3898294 in Survey of immunologic research as Clinical Trial, Journal Article, with publication-date metadata of 1985 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 11, 2026
Evidence lane
Literature metadata
Record added

Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.

PubMed lists PMID 3898297 in Survey of immunologic research as Clinical Trial, Journal Article, with publication-date metadata of 1985 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 20, 2026
Evidence lane
Literature metadata
Record added

Structural analysis of Salvia miltiorrhiza polysaccharide and its regulatory functions on T cells subsets in tumor-bearing mice combined with thymopentin.

PubMed lists PMID 39002910 in International journal of biological macromolecules as Journal Article, with publication-date metadata of 2024-07-11 (day precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
August 24, 2024
Evidence lane
Literature metadata
Record added

Self-assembled Palmitic Acid-modified Thymopentin Functions as a Delivery System of Nanovaccine for Cancer Immunotherapy.

PubMed lists PMID 39814680 in Chembiochem : a European journal of chemical biology as Journal Article, with publication-date metadata of 2025-02-04 (day precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 22, 2025
Evidence lane
Literature metadata
Record added

Immunomodulation with thymopentin in humans.

PubMed lists PMID 6398312 in International journal of clinical pharmacology research as Clinical Trial, Controlled Clinical Trial, Journal Article, with publication-date metadata of 1984 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 16, 2017
Evidence lane
Literature metadata
Record added

Thymopentin treatment of rheumatoid arthritis.

PubMed lists PMID 7818590 in Arzneimittel-Forschung as Clinical Trial, Journal Article, Randomized Controlled Trial, Review, with publication-date metadata of 1994-10 (month precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Management of viral infections with thymopentin.

PubMed lists PMID 7945525 in Arzneimittel-Forschung as Journal Article, Review, with publication-date metadata of 1994-07 (month precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Thymopentin prophylactic treatment in patients with recurrent respiratory infections.

PubMed lists PMID 8260339 in The British journal of clinical practice as Journal Article, Review, with publication-date metadata of 1993 Jul-Aug (source-text precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.

PubMed lists PMID 8838703 in AIDS (London, England) as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 1996-02 (month precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 18, 2019
Evidence lane
Literature metadata
Record added

[Recurrent urinary tract infections. Biological suppositions and clinical treatment with thymopentin].

PubMed lists PMID 9557507 in Minerva urologica e nefrologica = The Italian journal of urology and nephrology as Clinical Trial, English Abstract, Journal Article, with publication-date metadata of 1997-12 (month precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
January 26, 2017
Evidence lane
Literature metadata
Record added

Thymopentin and splenopentin as immunomodulators. Current status.

PubMed lists PMID 9638477 in Immunologic research as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 1998 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 11, 2026
Evidence lane
Literature metadata